Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.

Authors

Ahmed Naguy (ORCID: https://orcid.org/0000-0002-6465-456X)
Bibi Alamiri (ORCID: https://orcid.org/0000-0001-7133-9069)

Institutions

Amiri Hospital (KW)
Centre for Mental Health (GB)

Publication Details

Journal: Psychopharmacology Bulletin
Published: 2025-08-12
DOI: https://doi.org/10.64719/pb.4496
Citations: 1
Primary Topic: Neurotransmitter Receptor Influence on Behavior
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Ahmed Naguy, Bibi Alamiri

Aug 12, 2025

1 citations

Psychopharmacology Bulletin

Neurotransmitter Receptor Influence on Behavior

article

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Ahmed Naguy, Bibi Alamiri

August 12, 2025article en

1 citations

Abstract

Psychopharmacology BulletinVol. 54(3)

Amiri Hospital (KW), Centre for Mental Health (GB)

Openalex Percentile: Top 100%

Neurotransmitter Receptor Influence on Behavior

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology — Ahmed Naguy, Bibi Alamiri · Psychopharmacology Bulletin (2025) | TGRS Research Map | TGRS